29 Sep 2026, 08:49 IST
Zydus Lifesciences Limited
Motilal Oswal Financial Services Ltd.
The report notes the US FDA concluded its inspection of Zydus's Ahmedabad facility with just one observation, a mild outcome removing a key regulatory overhang.
From MOStMarketOutlook29092026, written by Motilal Oswal Financial Services Ltd. and hosted by Investment Guru India. Orivam summarised it; the view is Motilal Oswal Financial Services Ltd.'s, not Orivam's.
Open the original PDF on Investment Guru India →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.